Oxford Centre for Haematology
Presenter: Michel Delforge, Leuven
17 Oct (evening)
The Oxford Belfry, Milton Common
A NEW AGE IN AML
Chair: Dr Paresh Vyas
1 Nov, 5.30 pm
OXFORD STEM CELLL INSTITUTE SYMPOSIUM
12-13 Nov, St Hugh's College
CLINICAL GENOMICS & MOLECULAR DIAGNOSTICS WORKSHOP
Chair: Dr Anna Schuh, University of Oxford
19th Nov, 10:00 – 16:45
Oxford Spires Hotel, Oxford, OX1 4PS
The OCH Management Board has as members the Director of the OCH, the Head of Clinical Haematology, the Head of Laboratory Haematology, the Head of the Radcliffe Department of Medicine, the Head of the Nuffield Division of Clinical Laboratory Sciences, the Director of the MRC Molecular Haematology Unit, the Director of the MRC Human Immunology Unit, the RDM Research Strategy Coordinator and the Administrator of the OCH.
Quek L. et al, (2018), Nat Med
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S. et al, (2017), Nat Commun, 8
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
Giustacchini A. et al, (2017), Nat Med, 23, 692 - 702
Neo WH. et al, (2018), Blood, 131, 2223 - 2234
Desborough MJR. et al, (2018), Br J Haematol